Accumulation of the advanced glycation end product carboxymethyl lysine in breast cancer is positively associated with estrogen receptor expression and unfavorable prognosis in estrogen receptor-negative cases

Oxidative stress and glyoxalase I activity mediate dicarbonyl toxicity in MCF-7 mamma carcinoma cells and a tamoxifen resistant derivative

(2016) Norbert Nass et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Targeting of RAGE-ligand signaling impairs breast cancer cell invasion and metastasis

(2016) T Kwak et al.   ONCOGENE

Advanced glycation endproducts increase proliferation, migration and invasion of the breast cancer cell line MDA-MB-231

(2015) Hana Sharaf et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Tamoxifen resistance: From cell culture experiments towards novel biomarkers

(2015) Norbert Nass et al.   PATHOLOGY RESEARCH AND PRACTICE

Activation of endogenous antioxidants as a common therapeutic strategy against cancer, neurodegeneration and cardiovascular diseases: A lesson learnt from DJ-1

(2015) Julie Y.H. Chan et al.   PHARMACOLOGY & THERAPEUTICS

Methylglyoxal, the dark side of glycolysis

(2015) Igor Allaman et al.   Frontiers in Neuroscience

Triple negative tumors accumulate significantly less methylglyoxal specific adducts than other human breast cancer subtypes

(2015) Barbara Chiavarina et al.   Oncotarget

Glyoxalase I inhibition induces apoptosis in irradiated MCF-7 cells via a novel mechanism involving Hsp27, p53 and NF-κB

(2014) C Antognelli et al.   BRITISH JOURNAL OF CANCER

A molecular model for the mechanism of acquired tamoxifen resistance in breast cancer

(2014) Ping Fan et al.   EUROPEAN JOURNAL OF CANCER

Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update

(2014) Harold J. Burstein et al.   JOURNAL OF CLINICAL ONCOLOGY

Differential Response to α-Oxoaldehydes in Tamoxifen Resistant MCF-7 Breast Cancer Cells

(2014) Norbert Nass et al.   PLoS One

GPER Function in Breast Cancer: An Overview

(2014) Rosamaria Lappano et al.   Frontiers in Endocrinology

Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer

(2013) Rosalind Brigham Penney et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Estrogen Receptor-α Variant, ER-α36, is Involved in Tamoxifen Resistance and Estrogen Hypersensitivity

(2013) XianTian Zhang et al.   ENDOCRINOLOGY

NIH Image to ImageJ: 25 years of image analysis

(2012) Caroline A Schneider et al.   NATURE METHODS

The Warburg effect: Insights from the past decade

(2012) Mohita Upadhyay et al.   PHARMACOLOGY & THERAPEUTICS

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

(2011) Atanas Ignatov et al.   BREAST CANCER RESEARCH AND TREATMENT

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

With maturity comes confidence: EBCTCG tamoxifen update

(2011) Stephen K Chia et al.   LANCET

Glyoxalase in tumourigenesis and multidrug resistance

(2011) Paul J. Thornalley et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Glycation of PDGF results in decreased biological activity

(2010) Norbert Nass et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Influence of the interaction between nodal fibroblast and breast cancer cells on gene expression

(2010) Rosângela Portilho Costa Santos et al.   TUMOR BIOLOGY

Maillard Products as Biomarkers in Cancer

(2008) Beatrice E. Bachmeier et al.   Annals of the New York Academy of Sciences

Potential biomarkers of ageing

(2008) Andreas Simm et al.   BIOLOGICAL CHEMISTRY